| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |